z-logo
open-access-imgOpen Access
Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
Author(s) -
Brendan Flannery,
Jessie R. Chung,
Arnold S. Monto,
Emily T. Martin,
Edward A. Belongia,
Huong Q. McLean,
Manjusha Gaglani,
Kempapura Murthy,
Richard K. Zimmerman,
Mary Patricia Nowalk,
Michael L. Jackson,
Lisa A. Jackson,
Melissa A. Rolfes,
Sarah Spencer,
Alicia M. Fry,
Joshua G. Petrie,
Ryan E. Malosh,
Erin McSpadden,
Hannah E. Segaloff,
Caroline Cheng,
Rachel Truscon,
Emileigh Johnson,
Lois Lamerato,
Lynn Ivacic,
Jennifer P. King,
Jennifer K. Meece,
Madalyn M Palmquist,
Sherri A Guzinski,
Anne Robertson,
Ashley Kossie,
Michael Smith,
Vanessa Hoelscher,
Lydia Clipper,
Kimberley Walker,
Marcus Volz,
Arundhati Rao,
Robert Fader,
Yolanda Muñoz Maldonado,
Michael Reis,
John V. Williams,
G.K. Balasubramani,
Evelyn Cohen Reis,
Heather Eng,
Samantha Ford,
Todd Bear,
Edmund M. Ricci,
Robert W. Hickey,
Krissy Moehling Geffel,
Jonathan M. Raviotta,
Theresa M. Sax,
Michael Susick,
Monika Johnson,
Rose Azrak,
LaShondra Berman,
Angie Foust,
Wendy Sessions,
Juliana DaSilva,
Thomas Stark,
John Barnes
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy775
Subject(s) - medicine , influenza vaccine , virology , vaccination
In recent influenza seasons, the effectiveness of inactivated influenza vaccines against circulating A(H3N2) virus has been lower than against A(H1N1)pdm09 and B viruses, even when circulating viruses remained antigenically similar to vaccine components.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom